ROCK2 and cardiac hypertrophy: Studies using ROCK2 conventional and conditional knockout (cKO) mice have shown that the deletion of ROCK2 results in specific phenotypes, including placental dysfunction [10], pulmonary vasculopathy [11], cardiac hypertrophy, fibrosis and diastolic dysfunction [12], diabetic nephropathy [13], and anxiety‐like behavior [14].